Table 3.

Estimated Mean Counts (95% confidence interval) and Estimated Event Rate Ratio and (95% confidence interval) as a Function of Time for Objective Vasomotor Symptoms for Women Randomized to Active Stellate Ganglion Blockade (SGB) or the sham control.

	Treatment Group
	SGB (n=18)			Sham-Control (n=17)
	Baseline	3-months Post		Baseline	3-months Post
	M (95%CI)	M (95%CI)	RR (95%CI)	M (95%CI)	M (95%CI)	RR (95%CI)	RRR (95%CI)
Total	7.21 (3.68–14.1)	5.74 (2.92–11.3)	0.79 (0.64–0·98)*	5.60 (2.85–11.0)	6.24 (3.12–12.5)	1.11 (0.86–1.43)	0.71 (0.64–0.99)*
Awake	5.84 (2.93–11.6)	4.33 (2.17–8.66)	0.74 (0.59–0·94)*	3.95 (1.97–7.96)	4.48 (2.19–9.17)	1.13 (0.84–1.52)	0.66 (0.45–0.96)*
Sleep	1.66 (0.84–3.29)	1.66 (0.84–3.30)	1.00 (0.63–1.60)	1.36 (0.67–2.77)	1.45 (0.69–3.04)	1.06 (0.63–1.71)	0.94 (0.48–1.83)

Note.

^*p<0.05. SGB=Stellate Ganglion Blockade; CI= Confidence Interval. RRR=Ratio of Event Rate Ratios. Results are reflective of a mixed effects Poisson regression (random intercept only).